Douglas E. Williams - 10 Apr 2023 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Reporting relationship
EVP & President, R&D
Issuer ticker
SANA
Reported as of
10 Apr 2023
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Apr 2023, 16:26:28 UTC
Prior SEC filing
30 Mar 2023
Next SEC filing
03 Nov 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Bernard J. Cassidy, Attorney-in-Fact for Douglas E. Williams

Key filing fact

Douglas E. Williams filed Form 4 for Sana Biotechnology, Inc. (SANA) on 11 Apr 2023.

Key facts

  • This page summarizes Douglas E. Williams's Form 4 filing for Sana Biotechnology, Inc. (SANA).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 11 Apr 2023, 16:26.

Change

  • Previous filing in this sequence was filed on 30 Mar 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SANA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+1,100,000
Change %
Price
$0.000000
Shares after
1,100,000
Date
10 Apr 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,100,000
Exercise price
$3.28
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests and becomes exercisable as to 25% of the underlying shares on April 10, 2024 and in 36 equal monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .